France 2030
VC Fund
France 2030 is a VC fund focused on Biotechnology and Manufacturing. France 2030 is the Investments for the Future programme (PIA) that aim to stimulate employment, boost productivity and increase the competitiveness of French businesses by encouraging investment and innovation in priority sectors to drive growth.
- Total investments:
- 62
- Last investment:
- Lead investor:
- 65%
Last updated:
For AI agents: llms.txt
Industries France 2030 invests in
Stages France 2030 invests in
Countries France 2030 invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biotechnology 17 (27%)
- Manufacturing 10 (16%)
- Health Care 9 (15%)
- Medical 6 (10%)
- Therapeutics 6 (10%)
Stage
- Grant 42 (68%)
- Seed 5 (8%)
- Series A 3 (5%)
- Debt Financing 3 (5%)
- Venture - Series Unknown 2 (3%)
Country
- France 49 (79%)
- United States 2 (3%)
- The Netherlands 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bruno Bonnell
Secretary General for Investment
|
Secretary General for Investment | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases. Magali Richard, David Schilansky, and Céline Vallot co-founded the company in Paris, Ile-de-France, France. | $3.8M / Grant / Sep 10, 2026 | ||
| BrestPort is a port authority and management company that operates commercial, industrial, and energy logistics under a long-term concession contract. The company handles cargo terminals, ship repair facilities, and shipping lines while upgrading its quays to support the assembly and manufacturing needs of offshore renewable energy industries. | $66.9M / Grant / Aug 01, 2026 | ||
| Kahimmune Therapeutics is a cutting-edge biotech startup that is repurposing the cancer immunopeptidome to create next-generation immuno-oncology medicines. Kahimmune uses revolutionary insights into the "dark genome" to identify novel neoantigens, resulting in innovative cancer vaccinations developed for synergistic combination therapy. | $105.2K / Seed / Apr 28, 2026 | ||
| Jimmy develops and operates thermal generators that supply industrial facilities with process heat produced through nuclear fission. The company designs compact generators that use high-temperature reactor technology to create heat without combustion and deliver it to industrial systems through heat transfer circuits. Its systems connect to factoryinfrastructure and provide heat for processes such as steam production, thermal oil heating, or hot air generation. Jimmy installs, operates, and manages these generators as integrated energy units adapted to the heat demand of each industrial site. The technology relies on micro-reactor architecture and modular deployment so multiple units can be combined to match required thermal output. Through this approach, Jimmy provides industrial heat that replaces fossil-fuel-based heat sources in manufacturing and processing operations. | $46.5M / Grant / Mar 10, 2026 | ||
| C12 Quantum Electronics develop reliable quantum processors with carbon nanotubes. Its unique technology reduces drastically the error rate, making the platform a prime candidate for noisy intermediate-scale quantum applications. The Paris, Ile-de-France, France-based company was formed in 2019 by Pierre and Matthieu Desjardins. | $16.3M / Grant / Dec 19, 2025 | ||
| Nova Analytics offers a real-time analytics platform for Amazon sellers to monitor fees, PPC spend, and business performance. | $460.8K / Grant / Nov 24, 2025 | ||
| Hummink develops additive manufacturing technology designed to provide tools to design and manufacture at the nanoscale.It uses a patented technology that combines a nanometric pen with an oscillating microresonator to perform a capillary deposition of various liquids, thereby providing semiconductor molecular diagnostic industries with the toolsto build large objects with the same resolution and precision on millimetric to centimetric substrates.Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, Antoine Nigues established the company in Paris, Île-de-France in 2020. | $17.4M / Series A / Nov 17, 2025 | ||
| Exwayz is a software development platform that specializes in real-time 3D LiDAR processing solutions. | Grant / Nov 17, 2025 | ||
| IsentroniQ is a Semiconductor quantum processors manufacturing firm. | $8.7M / Pre-Seed / Oct 14, 2025 | ||
| Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rightsto drugs and technologies that can then be brought to the development phase. Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development. | $6.7M / Grant / Oct 02, 2025 | ||
| See all 62 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does France 2030 invest in?
France 2030 invests primarily in Biotechnology, Manufacturing and Health Care startups, most often at Grant and Seed stage. Most of the 62 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact France 2030?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at France 2030?
The team at France 2030 includes Bruno Bonnell (Secretary General for Investment). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
